25 May 2013
Keywords: fda, panel, withholds, backing, sorivudine, food, drug
Article | 17 June 1996
A US Food and Drug Administration advisory committee has declined to
recommend approval of Bristol-Myers Squibb's antiviral drug Bravavir
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
10 June 1996
1 July 1996
24 May 2013
© 2013 thepharmaletter.com